Cape Bio Pharms

About:

Cape Bio Pharms is a bio-research company that offers the production of recombinant proteins in Nicotiana benthamiana plants.

Website: http://www.capebiopharms.com

Twitter/X: capebiopharms

Top Investors: European Investment Bank, Foundation for Innovative New Diagnostics

Description:

Cape Bio Pharms is a biotech company that develops a plant-based platform for the production of proteins for rapid diagnostic test kits and biomedical research. The company's plans are designed to commercialize biotech for the production of recombinant proteins in tobacco, providing life scientists with a diverse range of premium, moderate, and custom plant-made recombinant proteins with reproducible results.

Total Funding Amount:

900M ZAR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cape Town, NA - South Africa, South Africa

Founded Date:

2018-01-01

Contact Email:

sales(AT)capebiologix.com

Founders:

Belinda Shaw

Number of Employees:

11-50

Last Funding Date:

2020-12-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai